تفاعل #808

ord-85b6b1948aa842f2a19dc52c1d84fd97

معادلة التفاعل

Cn1cnc(Nc2cc(Cl)nc3c(C#N)cnn23)c1
Cn1cnc(Nc2cc(Cl)nc3c
CC(=O)Nc1cc(N)ccc1C
CC(=O)Nc1cc(N)ccc1C
CC(=O)Nc1cc(Nc2cc(Nc3cn(C)cn3)n3ncc(C#N)c3n2)ccc1C
CC(=O)Nc1cc(Nc2cc(Nc
المردود 29.3%

المذيبات

ظروف التفاعل

درجة الحرارة
100°CELSIUS

الإجراء التجريبي

To a microwave vial containingN-(5-amino-2-methylphenyl)acetamide (0.120 g, 0.73 mmol), 5-chloro-7-(1-methyl-1H-imidazol-4-ylamino)pyrazolo[1,5-a]pyrimidine-3-carbonitrile (0.1 g, 0.37 mmol) ,sodium 2-methylpropan-2-olate (0.116 g, 1.21 mmol) and 2-Dicyclohexylphosphino-2',4',6'-tri-iso-propyl-1,1'-biphenyl (0.017 g, 0.04 mmol)was added DMA (2.2 ml). Vial was flushed with argon and to it was added Pd2(dba)3 (0.017 g, 0.02 mmol) and the reaction was heated in a MW reactor at 100 ° C for 60 min.Reaction was filtered, and filterate concentrated under reduced pressure to give dark red gum. This was suspended in 10% MeOH : DCM (10 ml) filtered and filterate concentrated to give crude solid. This was purified by flash column using 5-8% MeoH :DCM (1% NH4OH) to give 75 mg of pale yellow solid (EN02331-12-1). LCMS short purity indicated 90% pure. This sample was further purified by triturating the solid in 20% EtOAC: ether (10ml). The solid was filtered, dried to give pale yellow solid (EN 02331-12-2) as desired pdt. Mass spec and NMR are in agreement with the structure. (Note : The Etoac:Ether solution(filterate in the above step) obtained after trituration was concentrated to give solid (23 mg) this was stored for future use.

المصدر

750 AstraZeneca ELN dataset